EUROFINS SCIENT - 21 Year Stock Price History | ERFSF
Historical daily share price chart and data for EUROFINS SCIENT since 2005 adjusted for splits and dividends. The latest closing stock price for EUROFINS SCIENT as of February 09, 2026 is 81.66.
- The all-time high EUROFINS SCIENT stock closing price was 141.87 on September 03, 2021.
- The EUROFINS SCIENT 52-week high stock price is 86.20, which is 5.6% above the current share price.
- The EUROFINS SCIENT 52-week low stock price is 48.55, which is 40.5% below the current share price.
- The average EUROFINS SCIENT stock price for the last 52 weeks is 68.99.
| EUROFINS SCIENT Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2026 | 81.9272 | 74.4700 | 85.7700 | 74.4700 | 81.6600 | 11.41% |
| 2025 | 65.4862 | 51.0283 | 82.1400 | 45.8384 | 73.3000 | 41.36% |
| 2024 | 56.5587 | 63.5762 | 65.4869 | 45.8286 | 51.8547 | -17.54% |
| 2023 | 61.6915 | 67.1704 | 72.4920 | 46.0960 | 62.8858 | -9.64% |
| 2022 | 78.8743 | 114.6740 | 114.6740 | 52.8903 | 69.5932 | -42.26% |
| 2021 | 107.0636 | 81.9425 | 141.8650 | 81.9425 | 120.5240 | 55.21% |
| 2020 | 63.2186 | 53.2376 | 85.5425 | 40.5236 | 77.6545 | 45.56% |
| 2019 | 42.4936 | 34.6587 | 54.0566 | 31.2527 | 53.3498 | 51.54% |
| 2018 | 47.9414 | 58.6595 | 61.6670 | 33.1774 | 35.2060 | -37.62% |
| 2017 | 49.9453 | 40.1045 | 60.4491 | 38.6718 | 56.4342 | 43.50% |
| 2016 | 35.9680 | 32.3056 | 43.1839 | 28.7408 | 39.3283 | 20.21% |
| 2015 | 28.3267 | 23.6827 | 35.3064 | 22.8789 | 32.7164 | 39.36% |
| 2014 | 25.3683 | 25.0390 | 30.0788 | 20.2814 | 23.4760 | -6.46% |
| 2013 | 22.0539 | 17.7129 | 25.0975 | 17.7129 | 25.0975 | 70.55% |
| 2012 | 12.1969 | 6.5370 | 14.8289 | 6.5370 | 14.7153 | 103.40% |
| 2011 | 7.6430 | 7.4630 | 8.2312 | 7.2348 | 7.2348 | 66.13% |
| 2010 | 3.8085 | 3.8197 | 4.3549 | 3.2820 | 4.3549 | 8.86% |
| 2009 | 4.2406 | 4.2050 | 4.8607 | 3.7724 | 4.0004 | -3.88% |
| 2008 | 6.8350 | 9.2502 | 9.2502 | 3.4541 | 4.1620 | -46.89% |
| 2007 | 7.5336 | 6.9976 | 8.1110 | 6.9976 | 7.8370 | 32.90% |
| 2006 | 5.2303 | 4.3681 | 5.8970 | 4.3681 | 5.8970 | 60.13% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $15.545B | $8.253B |
| Eurofins Scientific SE provides testing services. The company provides food and feed testing, bioanalytical, biopharma, pharma discovery, pharma early development, pharma central laboratory, biopharma product testing, genomic, agroscience, consumer product testing, forensic, environment testing and REACH services. It operates primarily in Benelux, France, Germany, North America, Nordic countries, the United Kingdom, Ireland and internationally. Eurofins Scientific SE is headquartered in Luxembourg. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $157.813B | 28.64 |
| HCA Healthcare (HCA) | United States | $113.378B | 17.58 |
| CVS Health (CVS) | United States | $95.741B | 11.01 |
| Elevance Health (ELV) | United States | $75.968B | 11.33 |
| Cencora (COR) | United States | $70.528B | 22.74 |
| Natera (NTRA) | United States | $31.966B | 0.00 |
| Labcorp Holdings (LH) | United States | $22.407B | 17.08 |
| DiDi Global (DIDIY) | China | $22.168B | 20.48 |
| Medpace Holdings (MEDP) | United States | $16.568B | 41.13 |
| Viatris (VTRS) | United States | $15.756B | 5.87 |
| ICON (ICLR) | Ireland | $14.422B | 14.31 |
| Solventum (SOLV) | United States | $13.340B | 12.95 |
| BioMerieux (BMXMF) | France | $13.150B | 0.00 |
| CochLear (CHEOY) | Australia | $12.190B | 0.00 |
| Revvity (RVTY) | United States | $12.141B | 21.12 |
| Charles River Laboratories (CRL) | United States | $10.494B | 20.21 |
| Sonic Healthcare (SKHHY) | Australia | $8.046B | 0.00 |
| Avantor (AVTR) | United States | $7.548B | 11.53 |
| HealthEquity (HQY) | United States | $7.439B | 27.82 |
| BrightSpring Health Services (BTSG) | United States | $7.302B | 43.54 |
| Caris Life Sciences,�Inc (CAI) | United States | $6.580B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $5.940B | 39.00 |
| PACS (PACS) | United States | $5.544B | 33.71 |
| Sotera Health (SHC) | United States | $5.199B | 25.07 |
| Alignment Healthcare (ALHC) | United States | $4.532B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.719B | 21.70 |
| GeneDx Holdings (WGS) | United States | $2.862B | 50.26 |
| Concentras Parent (CON) | United States | $2.839B | 17.72 |
| Organon (OGN) | United States | $2.132B | 2.25 |
| Progyny (PGNY) | United States | $2.087B | 41.03 |
| Establishment Labs Holdings (ESTA) | United States | $2.070B | 0.00 |
| Surgery Partners (SGRY) | United States | $1.914B | 24.67 |
| Pediatrix Medical (MD) | United States | $1.841B | 10.99 |
| Ardent Health (ARDT) | United States | $1.230B | 4.01 |
| Nutex Health (NUTX) | United States | $1.140B | 8.72 |
| CareDx (CDNA) | United States | $1.050B | 17.16 |
| Teladoc Health (TDOC) | United States | $0.953B | 0.00 |
| Omada Health (OMDA) | United States | $0.861B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $0.774B | 12.67 |
| InnovAge Holding (INNV) | United States | $0.773B | 0.00 |
| Embecta (EMBC) | United States | $0.648B | 3.68 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.635B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.616B | 0.00 |
| Enhabit (EHAB) | United States | $0.545B | 24.48 |
| SBC Medicals (SBC) | United States | $0.505B | 9.28 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| CryoPort (CYRX) | United States | $0.482B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.408B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.391B | 82.38 |
| Auna S.A (AUNA) | Luxembourg | $0.356B | 5.73 |
| Agilon Health (AGL) | United States | $0.343B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.294B | 0.00 |
| So-Young (SY) | China | $0.284B | 0.00 |
| Oncology Institute (TOI) | United States | $0.264B | 0.00 |
| Beauty Health (SKIN) | United States | $0.191B | 0.00 |
| LifeMD (LFMD) | United States | $0.158B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.131B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.107B | 0.00 |
| Biodesix (BDSX) | United States | $0.082B | 0.00 |
| DocGo (DCGO) | United States | $0.076B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.071B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.042B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.042B | 0.00 |
| Pomdoctor - (POM) | China | $0.025B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.020B | 6.03 |
| OSR Holdings (OSRH) | United States | $0.014B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.014B | 0.00 |
| Lifeward (LFWD) | United States | $0.011B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.010B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| XWELL (XWEL) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |